Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sernova Biotherapeutics Inc (SEOVF)

Sernova Biotherapeutics Inc (SEOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 33,620
  • Shares Outstanding, K 331,232
  • Annual Sales, $ 0 K
  • Annual Income, $ -11,240 K
  • EBIT $ -9 M
  • EBITDA $ -23 M
  • 60-Month Beta 1.08
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.04
  • Most Recent Earnings $-0.01 on 12/19/25
  • Next Earnings Date 03/13/26
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0905 unch
on 12/29/25
0.1077 -15.97%
on 12/26/25
-0.0195 (-17.73%)
since 11/28/25
3-Month
0.0867 +4.38%
on 11/25/25
0.1450 -37.59%
on 10/06/25
-0.0422 (-31.80%)
since 09/26/25
52-Week
0.0867 +4.38%
on 11/25/25
0.1816 -50.17%
on 01/03/25
-0.0695 (-43.44%)
since 12/27/24

Most Recent Stories

More News
Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang

Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - October 1, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTCQB: SEOVF) (FSE: PSH0) ("Sernova") a leading regenerative medicine company focused...

SVA.TO : 0.1200 (-7.69%)
SEOVF : 0.0947 (-6.70%)
Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes

ELDN : 1.5550 (-2.81%)
SVA.TO : 0.1200 (-7.69%)
SEOVF : 0.0947 (-6.70%)
Sernova Appoints Jonathan Rigby as Interim Chair

SVA.TO : 0.1200 (-7.69%)
SEOVF : 0.0947 (-6.70%)
Chair of Sernova Biotherapeutics Resigns

SVA.TO : 0.1200 (-7.69%)
SEOVF : 0.0947 (-6.70%)
Sernova Biotherapeutics Appoints World-Class Clinical Advisory Board to Support Development of Cell Pouch Bio-hybrid Organ as Functional Cure for Type 1 Diabetes

SVA.TO : 0.1200 (-7.69%)
SEOVF : 0.0947 (-6.70%)
Sernova Biotherapeutics Provides Positive Interim Data from Ongoing Phase 1/2 Clinical Trial of Cell Pouch Bio-hybrid Organ in Patients Living with Type 1 Diabetes

SVA.TO : 0.1200 (-7.69%)
SEOVF : 0.0947 (-6.70%)
Sernova Biotherapeutics Secures $4 Million Loan to Further Advance its Clinical Development Plans

SVA.TO : 0.1200 (-7.69%)
SEOVF : 0.0947 (-6.70%)
Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med

SVA.TO : 0.1200 (-7.69%)
SEOVF : 0.0947 (-6.70%)
Sernova Biotherapeutics Provides Update on Phase 1/2 Clinical Trial of Cell Pouch™ Bio-Hybrid Organ for Treatment of Type 1 Diabetes

SVA.TO : 0.1200 (-7.69%)
SEOVF : 0.0947 (-6.70%)
Sernova Biotherapeutics Appoints Pericles Calias, Ph.D. as Chief Development Officer and Head of R&D

SVA.TO : 0.1200 (-7.69%)
SEOVF : 0.0947 (-6.70%)

Business Summary

Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cells to create a bio-hybrid organ. Sernova Biotherapeutics, formerly known as Sernova Corp., is based in LONDON, Ontario.

See More

Key Turning Points

3rd Resistance Point 0.1205
2nd Resistance Point 0.1141
1st Resistance Point 0.1078
Last Price 0.0947
1st Support Level 0.0951
2nd Support Level 0.0887
3rd Support Level 0.0824

See More

52-Week High 0.1816
Fibonacci 61.8% 0.1453
Fibonacci 50% 0.1341
Fibonacci 38.2% 0.1230
Last Price 0.0947
52-Week Low 0.0867

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar